FDA accepts Watson new drug application: "Watson Pharmaceuticals Inc. said Tuesday drug regulators accepted its application for a new drug to treat enlarged prostates.
Watson said the Food and Drug Administration agreed to review its silodosin application, which was backed by data from two late-stage clinical trials."